International patterns of dual antiplatelet therapy duration after acute coronary syndromes
H Bueno, S Pocock, N Danchin, L Annemans… - Heart, 2017 - heart.bmj.com
Objective To describe international patterns of dual antiplatelet therapy (DAPT) duration
after acute coronary syndrome (ACS), and explore its determinants and correlation with …
after acute coronary syndrome (ACS), and explore its determinants and correlation with …
[HTML][HTML] Evaluation of the use of dual antiplatelet therapy beyond the first year after acute coronary syndrome
C Bonanad, S Raposeiras-Roubin… - Journal of Clinical …, 2022 - mdpi.com
Clinical practice guidelines recommend extending dual antiplatelet therapy (DAPT) beyond
1 year after acute coronary syndrome (ACS) in patients with high ischemic risk and without …
1 year after acute coronary syndrome (ACS) in patients with high ischemic risk and without …
[HTML][HTML] Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome
There are limited real-world data on prevalence and predictors of dual antiplatelet therapy
(DAPT) prolongation beyond one year after acute coronary syndrome (ACS). We have …
(DAPT) prolongation beyond one year after acute coronary syndrome (ACS). We have …
Duration of dual antiplatelet therapy in patients with an acute coronary syndrome undergoing percutaneous coronary intervention
C Bavishi, V Trivedi, M Singh, E Katz… - The American journal of …, 2017 - Elsevier
Abstract Background The recent American Heart Association/American College of
Cardiology guidelines on duration of dual antiplatelet therapy (DAPT) recommend DAPT for …
Cardiology guidelines on duration of dual antiplatelet therapy (DAPT) recommend DAPT for …
Treatment pattern of contemporary dual antiplatelet therapies after acute coronary syndrome: a Swedish nationwide population-based cohort study
O Angerås, P Hasvold, M Thuresson… - Scandinavian …, 2016 - Taylor & Francis
Objectives New dual antiplatelet therapies (DAPTs) have been introduced in clinical practice
for patients with acute coronary syndrome (ACS). This nationwide study investigated DAPT …
for patients with acute coronary syndrome (ACS). This nationwide study investigated DAPT …
Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with percutaneous …
F D'ASCENZO, F Colombo, U Barbero… - Journal of …, 2014 - Wiley Online Library
Introduction Duration of dual antiplatelet therapy (DAPT) following acute coronary syndrome
(ACS) hospitalization remains to be defined, both for patients treated medically and for those …
(ACS) hospitalization remains to be defined, both for patients treated medically and for those …
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome: insights from a network meta-analysis …
T Kuno, H Ueyama, H Takagi, J Fox… - Cardiovascular …, 2021 - Elsevier
Background With newer generation drug eluting stents (DES), the minimal duration of dual
antiplatelet therapy (DAPT) recommended by guidelines has been reduced to 6 months in …
antiplatelet therapy (DAPT) recommended by guidelines has been reduced to 6 months in …
[HTML][HTML] Duration and clinical outcome of dual antiplatelet therapy after percutaneous coronary intervention: A retrospective cohort study using a medical information …
H Yokoi, E Oda, K Kaneko, K Matsubayashi - Cardiovascular Intervention …, 2022 - Springer
In this real-world, retrospective cohort study of 9753 patients in Japan prescribed dual
antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI), we …
antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI), we …
Initiation and persistence with dual antiplatelet therapy after acute myocardial infarction: a Danish nationwide population-based cohort study
Objectives The study investigated dual antiplatelet therapy (DAPT) patterns over time and
patient characteristics associated with the various treatments in a myocardial infarction (MI) …
patient characteristics associated with the various treatments in a myocardial infarction (MI) …
Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis
Introduction The decision to shorten the duration of DAPT following PCI in patients with ACS
remains controversial because of the concern for increased ischemic events. Methods We …
remains controversial because of the concern for increased ischemic events. Methods We …